OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
Sangkyu Park, Dongbum Kim, Guang Wu, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 8655-8672
Open Access | Times Cited: 15
Sangkyu Park, Dongbum Kim, Guang Wu, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 8655-8672
Open Access | Times Cited: 15
Showing 15 citing articles:
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 101
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 101
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 85
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 85
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara M. Mangsbo, Divya Nagarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 96
Stefania Cuzzubbo, Sara M. Mangsbo, Divya Nagarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 96
Liposome-based diagnostic and therapeutic applications for pancreatic cancer
Faisal Raza, Lauren Evans, Mahzad Motallebi, et al.
Acta Biomaterialia (2022) Vol. 157, pp. 1-23
Open Access | Times Cited: 53
Faisal Raza, Lauren Evans, Mahzad Motallebi, et al.
Acta Biomaterialia (2022) Vol. 157, pp. 1-23
Open Access | Times Cited: 53
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Anna Lucia Tornesello, Maria Tagliamonte, Maria Lina Tornesello, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1049-1049
Open Access | Times Cited: 62
Anna Lucia Tornesello, Maria Tagliamonte, Maria Lina Tornesello, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1049-1049
Open Access | Times Cited: 62
Improving the efficacy of peptide vaccines in cancer immunotherapy
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110721-110721
Closed Access | Times Cited: 16
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110721-110721
Closed Access | Times Cited: 16
Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges
Mohammad Zaki Ahmad, Javed Ahmad, Anzarul Haque, et al.
Expert Review of Vaccines (2020) Vol. 19, Iss. 11, pp. 1053-1071
Closed Access | Times Cited: 34
Mohammad Zaki Ahmad, Javed Ahmad, Anzarul Haque, et al.
Expert Review of Vaccines (2020) Vol. 19, Iss. 11, pp. 1053-1071
Closed Access | Times Cited: 34
Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors
Yoshie Kametani, Yusuke Ohno, Shino Ohshima, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6337-6337
Open Access | Times Cited: 32
Yoshie Kametani, Yusuke Ohno, Shino Ohshima, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6337-6337
Open Access | Times Cited: 32
State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
Nur Syafiqah Rahim, Yuan Seng Wu, Maw Shin Sim, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
Nur Syafiqah Rahim, Yuan Seng Wu, Maw Shin Sim, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
Theranostic nanoparticles for detection and treatment of pancreatic cancer
Happy Agarwal, Ryan C. Bynum, Nada Saleh, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 3
Happy Agarwal, Ryan C. Bynum, Nada Saleh, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 3
Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines
Tianyu Shi, Mengna Sun, Changchang Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Tianyu Shi, Mengna Sun, Changchang Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Nanomaterials for oncotherapies targeting the hallmarks of cancer
Xiaofeng Dai, Lihui Yu, Xijiang Zhao, et al.
Nanotechnology (2020) Vol. 31, Iss. 39, pp. 392001-392001
Closed Access | Times Cited: 12
Xiaofeng Dai, Lihui Yu, Xijiang Zhao, et al.
Nanotechnology (2020) Vol. 31, Iss. 39, pp. 392001-392001
Closed Access | Times Cited: 12
Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer
Xinqiao Wang, Xue Qiong Yin, Yuxin Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Xinqiao Wang, Xue Qiong Yin, Yuxin Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Targeting TM4SF5 with anti‑TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
Sangkyu Park, Dongbum Kim, Jeong‐A Park, et al.
Oncology Letters (2019)
Open Access | Times Cited: 6
Sangkyu Park, Dongbum Kim, Jeong‐A Park, et al.
Oncology Letters (2019)
Open Access | Times Cited: 6
